
T.G.Fit 200mg Tablet
Marketer
Morepen Laboratories Ltd
Salt Composition
Fenofibrate (200mg)
Overview T.G.Fit 200mg Tablet
CholestoReduce 200mg tablets effectively manage high cholesterol. This medication lowers harmful triglycerides and LDL ("bad") cholesterol, concurrently increasing beneficial HDL ("good") cholesterol. Reduced cholesterol significantly lessens the risk of heart attack and stroke. Always adhere to your physician's prescribed dosage and regimen for CholestoReduce 200mg tablets. While it can be taken anytime with food, consistency is key – take it at the same time daily. High cholesterol often presents no symptoms, yet discontinuing treatment can worsen the condition, potentially raising cholesterol levels and increasing cardiovascular risks. Regular cholesterol monitoring is crucial. This medication forms part of a comprehensive treatment plan, encompassing a balanced diet, regular physical activity, smoking cessation, moderate alcohol consumption, and weight management. Maintain a normal diet while taking this medication, limiting high-fat foods. Common side effects may include nausea, stomach upset, diarrhea, and vomiting. Inform your doctor of all other medications before starting this treatment. Caution is advised if you have kidney or liver disease. Pregnant or breastfeeding individuals should consult their doctor before use.
Uses of T.G.Fit 200mg Tablet
Elevated cholesterol and triglyceride levels
Major Benefits of T.G.Fit 200mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 200mg T.G.Fit tablet whole; do not crush, chew, or divide it. Administer with a meal.
Common Side effects of T.G.Fit 200mg Tablet:
- Abdominal pain
- Diarrhea
- Nausea
- Headache
- Flatulence
- Vomiting
- Increased liver enzymes
- Increased creatine phosphokinase (CPK) level in blood
- Back pain
- Inflammation of the nose
How to use T.G.Fit 200mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 200mg T.G.Fit tablet whole; avoid chewing, crushing, or breaking it. Administer with a meal.
How T.G.Fit 200mg Tablet works:
T.G.Fit 200mg tablets reduce lipid levels. This medication lowers triglycerides and low-density lipoprotein (LDL, or "bad") cholesterol, concurrently increasing high-density lipoprotein (HDL, or "good") cholesterol.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while taking a 200mg T.G.Fit tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of T.G.Fit 200mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of T.G.Fit 200mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by T.G.Fit 200mg Tablets.
KidneyCAUTION
Patients with kidney impairment should use T.G.Fit 200mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. T.G.Fit 200mg tablets are contraindicated in individuals with severely compromised kidney function.
LiverUNSAFE
Individuals with liver disease should likely avoid T.G.Fit 200mg Tablets, as their use may be unsafe. Medical advice is recommended. The 200mg T.G.Fit Tablet is contraindicated in patients exhibiting severe hepatic impairment.
What if you forget to take T.G.Fit 200mg Tablet :
Should you forget a T.G.Fit 200mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About T.G.Fit 200mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Fibric acid-based compound |
| Developing Good Habits | No. |
| Type of Therapy | Heart |
| Actions | Fibrates (PPARα agonists) |
